Format

Send to

Choose Destination
See comment in PubMed Commons below
Stroke. 2006 Aug;37(8):2168-9. Epub 2006 Jun 22.

Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke.

Author information

1
Department of Neurology, University of Illinois at Peoria, OSF St. Francis Medical Center, 530 NE Glen Oak Ave, Peoria, IL 61637, USA. kathleenwiese@yahoo.com

Abstract

BACKGROUND AND PURPOSE:

Historically, the use of tissue plasminogen activator (tPA) thrombolysis in pregnancy has been regarded as relatively contraindicated. Underlying this stance has been the concern over the risk of bleeding complications in both mother and child.

SUMMARY OF CASE:

We report the successful use of intravenous recombinant tPA (rtPA) thrombolysis in a pregnant woman with acute cardioembolic stroke.

CONCLUSIONS:

The patient improved clinically, did not develop complications after receiving rtPA, and at 37 weeks' gestation, delivered a healthy infant, demonstrating that rtPA thrombolysis may be used safely in pregnant women.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center